PRUEBA PARA LA DETERMINACIÓN CUANTITATIVA DE LA ISOENZIMA CREATINA QUINASA MB (CK-MB) PRESENTE EN EL
Mexico·Clase I·III. Agentes de diagnóstico·DICIPA, S.A. DE C.V.·Registered April 01, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- SET DE REACTIVOS PARA CREATINA QUINASA MB (CK-MB).
- Trade Name (English)
- SET DE REACTIVOS PARA CREATINA QUINASA MB (CK-MB).
- Analysis ID
- 0262R2022 SSA
- Registration Date
- April 01, 2022
- Name (Spanish)
- DICIPA, S.A. DE C.V.
- Name (English)
- DICIPA, S.A. DE C.V.
Access comprehensive regulatory information for PRUEBA PARA LA DETERMINACIÓN CUANTITATIVA DE LA ISOENZIMA CREATINA QUINASA MB (CK-MB) PRESENTE EN EL (PRUEBA PARA LA DETERMINACIÓN CUANTITATIVA DE LA ISOENZIMA CREATINA QUINASA MB (CK-MB) PRESENTE EN EL) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 0262R2022 SSA and manufactured by DICIPA, S.A. DE C.V.. The device was registered on April 01, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.